Millipore Announces Full Commercial Availability Of Handheld Automated Cell Counter
Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it has begun full commercial shipments of its Scepter™ Handheld Automated Cell Counter to customers worldwide.
The Scepter instrument miniaturizes Coulter cell counting technology found in much larger instruments into a portable device the size of an automated pipette. A graphical display reports the cell count and average cell volume within 20 seconds of inserting the sensor into a cell culture sample. The product, which was announced in the fourth quarter of 2009, has generated strong interest from leading government and commercial laboratories. Millipore expects to continue to increase shipments in North America, Europe, Japan, Asia and Latin America through the remainder of the year.
“We continue to move aggressively to bring innovation and productivity enhancements to the life science research market,” said John Sweeney, Vice President of Millipore’s Life Science business. “With the introduction of the Scepter instrument, we now have a range of tools that help life scientists simplify tedious, repetitive tasks and improve the reproducibility of their experiments.”
In addition to counting cells, the Scepter instrument gives researchers immediate insights into cell health. For example, scientists are using the instrument to monitor the transformation of stem cells to a differentiated state. The novel instrument is also being evaluated for such diverse applications as identifying cell types prior to forensic analysis and analyzing the size and consistency of particles during the commercial production of ink.Additional Resources www.millipore.com/scepter About Millipore Millipore (NYSE: MIL) is a life science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees worldwide. For more information, visit www.millipore.com. ADVANCING LIFE SCIENCE TOGETHER ® Research. Development. Production.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV